Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial
- DOI
- 10.1186/s12885-023-11397-x
- Published
- 2023-09-19
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-023-11397-x,
title = {Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial},
author = {Simon Crabb and Robin Wickens and Sarah Jane-Bibby and Denise Dunkley and Megan Lawrence and Allen Knight and Robert Jones and Alison Birtle and Robert Huddart and Mark Linch and Jonathan Martin and Adam Coleman and Konstantinos Boukas and Hannah Markham and Gareth Griffiths},
year = {2023},
journal = {BMC Cancer},
doi = {10.1186/s12885-023-11397-x},
url = {https://doi.org/10.1186/s12885-023-11397-x}
}RIS
TY - JOUR TI - Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial AU - Simon Crabb AU - Robin Wickens AU - Sarah Jane-Bibby AU - Denise Dunkley AU - Megan Lawrence AU - Allen Knight AU - Robert Jones AU - Alison Birtle AU - Robert Huddart AU - Mark Linch AU - Jonathan Martin AU - Adam Coleman AU - Konstantinos Boukas AU - Hannah Markham AU - Gareth Griffiths PY - 2023 JO - BMC Cancer DO - 10.1186/s12885-023-11397-x UR - https://doi.org/10.1186/s12885-023-11397-x ER -
APA
Crabb, S., Wickens, R., Jane-Bibby, S., Dunkley, D., Lawrence, M., Knight, A., Jones, R., Birtle, A., Huddart, R., Linch, M., Martin, J., Coleman, A., Boukas, K., Markham, H., & Griffiths, G. (2023). Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial. BMC Cancer. https://doi.org/10.1186/s12885-023-11397-x
Source records
- crossref · retrieved 2026-09-26T18:24:38.943Z